Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials

European Journal of Cancer

Volumn 51, Issue 2, 2015, Pages 166-176

  Faron, Matthieu ^a   Pignon, Jean Pierre ^a   Malka, David ^a   Bourredjem, Abderrahmane ^a   Douillard, Jean Yves ^b   Adenis, Antoine ^c   Elias, Dominique ^a   Bouché, Olivier ^d   Ducreux, Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE RENÉ GAUDUCHEAU   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d SERVICE DE DERMATOLOGIE   (France)

Author keywords

Chemotherapy; Colorectal cancer; Meta analysis; Metastasis; Prognosis; Surgery

Indexed keywords

ALKALINE PHOSPHATASE; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; IRINOTECAN; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; HUMAN; LEUKOCYTE COUNT; META ANALYSIS; METASTASIS; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR DIFFERENTIATION; UNRESECTABLE SYNCHRONOUS METASTASIS; AGED; BLOOD; COLORECTAL NEOPLASMS; FEMALE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STANDARDS;

AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925449173     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.10.023     Document Type: Article

References (44)

1. World Health Organisation: GLOBOCAN [Internet]. http://www-dep.iarc.fr/, 2008. Available from: http://globocan.iarc.fr/.
2. R.J. De Haas, D.A. Wicherts, and P. Andreani Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection Ann Surg 253 2011 1069 1079
3. L.K.F. Temple, L. Hsieh, and W.D. Wong Use of surgery among elderly patients with stage IV colorectal cancer J Clin Oncol 22 2004 3475 3484
4. A.D. Cook, R. Single, and L.E. McCahill Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000 Ann Surg Oncol 12 2005 637 645
5. L.E. McCahill, G. Yothers, and S. Sharif Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10 J Clin Oncol 30 2012 3223 3228
6. C.R. Scoggins, I.M. Meszoely, and C.D. Blanke Nonoperative management of primary colorectal cancer in patients with stage IV disease Ann Surg Oncol 6 1999 651 657
7. S.A. Rosen, J.F. Buell, and A. Yoshida Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135 2000 530 534 discussion 534-35
8. A.I. Sarela, J.A. Guthrie, and M.T. Seymour Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer Br J Surg 88 2001 1352 1356
9. G.M. Nash, L.B. Saltz, and N.E. Kemeny Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease Ann Surg Oncol 9 2002 954 960
10. L. Ruo, C. Gougoutas, and P.B. Paty Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients J Am Coll Surg 196 2003 722 728
11. N.C. Tebbutt, A.R. Norman, and D. Cunningham Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases Gut 52 2003 568 573
12. P. Michel, I. Roque, and F. Di Fiore Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 28 2004 434 437
13. S. Benoist, K. Pautrat, and E. Mitry Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 92 2005 1155 1160
14. S. Stelzner, G. Hellmich, and R. Koch Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis J Surg Oncol 89 2005 211 217
15. S.K. Liu, J.M. Church, and I.C. Lavery Operation in patients with incurable colon cancer-is it worthwhile? Dis Colon Rectum 40 1997 11 14
16. A. Bajwa, N. Blunt, and S. Vyas Primary tumour resection and survival in the palliative management of metastatic colorectal cancer Eur J Surg Oncol 35 2009 164 167
17. A. Eisenberger, R.L. Whelan, and A.I. Neugut Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review Int J Colorectal Dis 23 2008 559 568
18. M.D. Evans, X. Escofet, and S.S. Karandikar Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer World J Surg Oncol 7 2009 28 35
19. G. Galizia, E. Lieto, and M. Orditura First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases Arch Surg 143 2008 352 358 discussion 358
20. M.S. Kaufman, N. Radhakrishnan, and R. Roy Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study Colorectal Dis 10 2008 498 502
21. S. Venderbosch, J.H. de Wilt, and S. Teerenstra Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature Ann Surg Oncol 18 2011 3252 3260
22. M. Ducreux, O. Bouche, and J.P. Pignon Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial Oncology 70 2006 222 230
23. F. Ferrand, D. Malka, and A. Bourredjem Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601 Eur J Cancer 49 2013 90 97
24. M. Ducreux, D. Malka, and J. Mendiboure Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial Lancet Oncol 12 2011 1032 1044
25. M. Ducreux, A. Adenis, and J. Mendiboure Efficacy and safety of bevacizumab (BEV)-based combination regimens in patients with metastatic colorectal cancer (mCRC): Randomized phase II study of BEV + FOLFIRI versus BEV + XELIRI (FNCLCC ACCORD-13/0503 study) ASCO Meeting Abstr 27 2009 4086
26. M. Ducreux, J. Bennouna, and M. Hebbar Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer Int J Cancer 128 2011 682 690
27. A.B. Miller, B. Hoogstraten, and M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
28. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
29. A. Marshall, D. Altman, and R. Holder Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study BMC Med Res Methodol 10 2010 112 122
30. A. Marshall, D.G. Altman, and R.L. Holder Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines BMC Med Res Methodol 9 2009 57 65
31. M. Dwass Modified randomization tests for nonparametric hypotheses Ann Math Statist 28 1957 181 187
32. J.P. Pignon, and C. Hill Meta-analyses of randomised clinical trials in oncology Lancet Oncol 2 2001 475 482
33. D.J. Fisher, A.J. Copas, and J.F. Tierney A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners J Clin Epidemiol 64 2011 949 967
34. R Development Core Team: R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria, R Foundation for Statistical Computing. Available from: http://www.R-project.org/; 2000.
35. B.S. Lin, A. Ziogas, and T.E. Seery Role of surgical resection among chemotherapy-treated patients with colorectal cancer stage IV disease: A survival analysis J Clin Oncol 29 2011 3564 [Meeting Abstracts]
36. A.P. Stillwell, P.G. Buettner, and Y.H. Ho Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone World J Surg 34 2010 797 807
37. C. Clancy, J.P. Burke, and M. Barry A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival Ann Surg Oncol 2014
38. M. Karoui, F. Roudot-Thoraval, and F. Mesli Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study Dis Colon Rectum 54 2011 930 938
39. M. Koopman, N.F. Antonini, and J. Douma Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Lancet 370 2007 135 142
40. J. Tol, M. Koopman, and A. Cats Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer N Engl J Med 360 2009 563 572
41. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
42. J. Robins, M.Á. Hernán, and B. Brumback Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560
43. R.C. Flanigan, S.E. Salmon, and B.A. Blumenstein Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655 1659
44. G.E. Van der Wal, A.S.H. Gouw, and J.A.A.M. Kamps Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil Ann Surg 255 2012 86 94